483
Genentech, Inc.FDA 483 - Genentech, Inc.
Record Details
During an inspection from May 17-21, 2021, the FDA observed that Genentech, Inc. in Hillsboro, OR, lacked adequate control procedures for monitoring manufacturing processes. Specifically, the firm failed to establish controls to address variability in the fill volume of drug product vials, including during vial filling and at batch completion. This indicates a significant concern regarding the quality control of their pharmaceutical manufacturing operations.
- Company
- Genentech, Inc.
- Product type
- drugs
View Company Profile
ID · eae90920-9665-4fba-aa4f-c73542a1798d
Other documents for Genentech, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.